Skip to main content

and
  1. Article

    Open Access

    Map** of diseases from clinical medicine research—a visualization study

    By employing bibliometric method, this study aimed to visualize the research hotspots and correlations among clinical medicine subjects. Literatures were retrieved from the PubMed database based on MeSH words ...

    Yilong Chen, Yiting Dong, Yu Zeng, **aoyan Yang, Jiantong Shen in Scientometrics (2020)

  2. Article

    Open Access

    Clinical efficacy, safety and tolerability of Aliskiren Monotherapy (AM): an umbrella review of systematic reviews

    Aliskiren is a newly developed drug. Its role in lowering BP has been recognized. However, the role of aliskiren in treating heart and renal diseases are still controversial.

    Qiyuan Zhao, Jiantong Shen, **gya Lu, Qi Jiang in BMC Cardiovascular Disorders (2020)

  3. Article

    Open Access

    MicroRNA-378 protects against intestinal ischemia/reperfusion injury via a mechanism involving the inhibition of intestinal mucosal cell apoptosis

    Intestinal ischemia/reperfusion (I/R) injury remains a major clinical event and contributes to high morbidity and mortality rates, but the underlying mechanisms remain elusive. Recent studies have demonstrated...

    Yunsheng Li, Shihong Wen, ** Yao, Weifeng Liu, Jiantong Shen in Cell Death & Disease (2017)

  4. Article

    Open Access

    Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies

    The effect of glucagon-like peptide-1(GLP-1) receptor agonists on heart failure remains uncertain. We therefore conducted a systematic review to assess the possible impact of GLP-1 agonists on heart failure or...

    Ling Li, Sheyu Li, Jiali Liu, Ke Deng, Jason W. Busse in BMC Cardiovascular Disorders (2016)